Post-Traumatic Stress Disorder (PTSD) occurs by experiencing life-threatening events such as natural disasters, serious accidents, military combat, terrorist incidents, or sexual assault in adult or childhood. Most survivors of trauma return to normal given a little time. However, some people will have stress reactions that do not go away on their own or may even get worse over time. These individuals might develop PTSD. People who have PTSD often remember their experience through flashbacks or nightmares. They may have difficulty sleeping and may feel detached as these symptoms can be severe enough and might last long enough to impair the person’s daily life significantly.
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/8376
According to MRFR analysis, the global post-traumatic stress disorder (PTSD) market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 7.3 billion in 2018.
Post-Traumatic Stress Disorder (PTSD) develops when a person is exposed to a traumatic event such as warfare, violent sexual assault, or other severe threats on a person’s life. A person with PTSD is at a higher risk for suicide and intentional self-harm. Children under the age of 10 are less likely to develop PTSD than adults. Prevention is possible when therapy is targeted at those with early symptoms but is not valid when carried out among all people following trauma. The chief treatments for people with PTSD are counseling and medication.
The global post-traumatic stress disorder (PTSD) market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
The global post-traumatic stress disorder (PTSD) market has been segmented based on treatment and end user.
The market, based on treatment, has been divided into psychotherapy and medication. The psychotherapy has been further segmented into cognitive therapy, exposure therapy, and eye movement desensitization and reprocessing (EMDR). The medication has been segmented into antidepressants, anti-anxiety medications, and prazosin. The antidepressants are classified as paroxetine, sertraline, mirtazapine, and amitriptyline, or phenelzine. The anti-anxiety drugs have been classified as beta-blockers and benzodiazepines. The medication segment is expected to hold the largest segment during the forecasted period.
The end user segment of the market are hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and surgery.
Some of the key players in the global post-traumatic stress disorder (PTSD) market are Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Bionomics (Australia), Greenstone LLC (US), GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), H. Lundbeck A/S (Denmark), Tonix Pharmaceuticals Holding Corp. (US), and Mylan NV (US).
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of PTSD and rising per capita healthcare expenditure. The post-traumatic stress disorder (PTSD) market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European post-traumatic stress disorder (PTSD) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The post-traumatic stress disorder (PTSD) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Asia Pacific region is the fastest region due to the increasing cases of sexual assault and road accidents and raising awareness about the treatment methods. The post-traumatic stress disorder (PTSD) market in the Middle East & Africa has been divided into the Middle East and Africa.
Global AI in Drug Discovery Market Research Report—Forecast till 2025
Global Patient Blood Management Market Research Report—Forecast till 2025
Global 4D Printing in Healthcare Market Research Report—Forecast till 2025
Global Pain Patch Market Research Report—Forecast till 2025
Body Composition Analyzers Market Research Report – Global Forecast till 2025
Anxiety Disorder Treatment Market Research Report – Global Forecast till 2025
Orthopedic Braces Market Research Report – Global Forecast till 2025
Mortuary Equipment Market Research Report – Global Forecast till 2024
Automatic Pill Dispenser Market Research Report – Global Global Forecast till 2024
Pharmacy Benefit Management Services Market Research – Global Forecast 2024
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.